{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-006611","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2023-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.799207+00:00","generated_at":"2026-06-10T09:36:16.072842+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Sunshine Biopharma gets 180-day Nasdaq bid-price compliance extension to March 18, 2024","bullets":["Received 180-day Nasdaq extension until March 18, 2024 to meet $1.00 min bid price.","Company meets all other continued listing requirements except bid price.","Intends to cure deficiency, potentially via reverse stock split if necessary.","No immediate effect on listing or trading; common stock continues on Nasdaq under 'SBFM'.","Compliance can be regained if closing bid price ≥$1.00 for 10 consecutive business days before deadline."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-006611","json":"https://secwatch.observer/filing/0001683168-23-006611.json","markdown":"https://secwatch.observer/filing/0001683168-23-006611.md","text":"https://secwatch.observer/filing/0001683168-23-006611.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316823006611/0001683168-23-006611-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316823006611/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T09:36:16.072842+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}